The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Antipsychotics: treatment of schizophrenia and other therapeutic options

Authors:

Sivolap Iu.P.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10): 74‑78

DOI: 10.17116/jnevro201911910174

Read: 10846 times

Download PDF (RU)
Contact the author
Table of contents

ANTIPSYCHOTICS: TREATMENT OF SCHIZOPHRENIA AND OTHER THERAPEUTIC OPTIONS
ANTIPSYCHOTICS: TREATMENT OF SCHIZOPHRENIA AND OTHER THERAPEUTIC OPTIONS

To cite this article:

Sivolap IuP. Antipsychotics: treatment of schizophrenia and other therapeutic options. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10):74‑78. (In Russ.)
https://doi.org/10.17116/jnevro201911910174

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50
Analysis of cognitive status in patients with different noso­logies and clinical variants of very late mani­festing schi­zophreniform psychosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):88-93
FA2H gene-associated spastic para­plegia (SPG35) — fami­lial case with late onset. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):137-144
Modern concepts of sleep disturbances asso­ciated with mental diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):7-12
Mental diso­rders in mili­tary personnel at the stage of medi­cal care in a multidisciplinary mili­tary medi­cal orga­nization. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):37-44
Asso­ciation of cortisol levels with psychopathological features of depression and therapeutic response in female patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):45-54
Factors supporting chro­nic inflammation in mental illness. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):7-15
Pediatric autoimmune ence­phalitis: A clinical asse­ssment by a psychiatrist. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):144-149
Abstract:

Antipsychotics are used in the treatment of schizophrenia and other psychoses, as well as bipolar disorder, anxiety disorders, obsessive-compulsive disorder, post-traumatic stress disorder, and specific types of personality disorders. Due to better tolerability, as well as some advantages of the pharmacological profile, the second-generation antipsychotics are preferred in clinical practice. A special place among antipsychotics is taken by sulpiride, which shows the ability to improve the condition of patients with different types of mental disorders as well as with internal diseases.

Keywords:

mental disorders
schizophrenia
first-generation neuroleptics
second-generation neuroleptics

Authors:

Sivolap Iu.P.

Moskovskaia meditsinskaia akademiia im. I.M. Sechenova

Close metadata

References:

  1. Taminga C. Antipsychotic Drugs. In: MSD Manual Professional Version, 2019; https://www.msdmanuals.com/professional/psychiatric-disorders/schizophrenia-and-related-disorders/antipsychotic-drugs
  2. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, Kreyenbuhl J. American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(2 suppl):1-56.
  3. Schatzberg A, DeBattista C. Manual of Clinical Psychopharmacology (Eight Edition). Washington, DC: American Psychiatric Publishing; 2015.
  4. Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM. HGDH Study Group. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003;160(8):1396-1404. https://doi.org/10.1176/appi.ajp.160.8.1396
  5. Semple D, Smyth R. Oxford handbook of psychiatry (third edition). Oxford: Oxford University Press; 2013.
  6. Harrison P, Cowen P, Burns T, Fazel M. Shorter oxford textbook of psychiatry. Seventh edition. Oxford: Oxford University Press; 2018.
  7. Spina E, de Leon J. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Expert Opin Drug Metab Toxicol. 2014;10(5):721-746. https://doi.org/10.1517/17425255.2014.885504
  8. Pignon B, Tezenas du Montcel C, Carton L, Pelissolo A. The place of antipsychotics in the therapy of anxiety disorders and obsessive-compulsive disorders. Curr Psychiatry Rep. 2017;19(12):103. https://doi.org/10.1007/s11920-017-0847-x
  9. Freire RC, Zugliani MM, Garcia RF, Nardi AE. Treatment-resistant panic disorder: a systematic review. Expert Opin Pharmacother. 2016;17(2):159-168. https://doi.org/10.1517/14656566.2016.1109628
  10. Perna G, Alessandra A, Raffaele B, Elisa M, Giuseppina D, Paolo C, Maria N, Daniela C. Is there room for second-generation antipsychotics in the pharmacotherapy of panic disorder? A systematic review based on PRISMA Guidelines. Int J Mol Sci. 2016;17(4):551;. https://doi.org/10.3390/ijms17040551
  11. Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012;18(5 suppl B):1-20.
  12. Skodol A. Overview of Personality Disorders. In: MSD Manual Professional Version, 2019; https://www.msdmanuals.com/professional/psychiatric-disorders/personality-disorders/overview-of-personality-disorders
  13. Huang CW, Chiu YW, Chen PJ, Yu NW, Tsai HJ, Chang CM. Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005—2013: a population-based study. Psychiatry Clin Neurosci. 2019. https://doi.org/10.1111/pcn.12861
  14. Mosolov SN. Modern trends in the treatment of schizophrenia. eglonil place in therapy of acute and chronic psychosis. Psihiatrija i Psihofarmakoterapija. 2000;2(3):3-6. (In Russ.)
  15. Ovsyannikov SA. Sulpiride — an atypical antipsychotic of a wide spectrum of action. Psihiatrija i Psihofarmakoterapija. 2003;5(2):72-73. (In Russ.)
  16. Tyuvina NA, Balabanova VV, Goncharova EM. Experience in using sulpiride in non-psychotic endogenous depressive-hypochondriacal disorders. Nevrologija, Nejropsihiatrija, Psihosomatika. 2012;4(1):67-71. (In Russ.) https://doi.org/10.14412/2074-2711-2012-365
  17. Statsenko OA, Drozdovsky YuV, Kralya OV. Sulpiride in complex therapy of agoraphobia with panic disorder. Rossijskij Psihiatricheskij Zhurnal. 2011;2:63-68. (In Russ.)
  18. Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, Arndt T, Bäckers L, Rothe P, Cipriani A, Davis J, Salanti G, Leucht S. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019. https://doi.org/10.1016/S0140-6736(19)31135-3
  19. Rothenberger A, Roessner V. Psychopharmacotherapy of obsessive-compulsive symptoms within the framework of Tourette syndrome. Curr Neuropharmacol. 2018. https://doi.org/10.2174/1570159X16666180828095131
  20. Hsieh YH, Chan HL, Lin CF, Liang SH, Lu ML, McIntyre RS, Lee Y, Lin TC, Chiu WC, Chen VC. Antipsychotic use is inversely associated with gastric cancer risk: a nationwide population-based nested case-control study. Cancer Med. 2019. https://doi.org/10.1002/cam4.2329
  21. Yao QY, Li J, Chen R, Yao Y, Xue JS, Chen WJ, Lu W, Zhou TY. Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer. Acta Pharmacol Sin. 2019. https://doi.org/10.1038/s41401-019-0251-7
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.